Breaking News Instant updates and real-time market news.

VCEL

Vericel

$16.68

5.15 (44.67%)

12:49
11/06/18
11/06
12:49
11/06/18
12:49

Vericel price target raised to $20 from $17 at BTIG

BTIG analyst Ryan Zimmerman raised his price target on shares of Vericel to $20 from $17 after the company delivered a "strong" Q3 report with growth for both MACI and Epicel. He did not expect the pace of adoption to increase as fast as it has, said Zimmerman, who believes a lack of incoming competition in FY19 and a growing sales force make it "hard to imagine" the stock will not see multiple expansion even as estimates move higher. Zimmerman keeps a Buy rating on Vericel shares.

  • 06

    Nov

  • 15

    Nov

VCEL Vericel
$16.68

5.15 (44.67%)

11/06/18
PIPR
11/06/18
NO CHANGE
Target $19
PIPR
Overweight
Vericel price target raised to $19 from $14 at Piper Jaffray
Piper Jaffray analyst Edward Tenthoff noted that Vericel increased product sales guidance again following the company's Q3 report and he now projects product sales of $89M this year and $113.5M in 2019. Based on the increased product sales forecast, Tenthoff raised his price target on Vericel to $19 from $14 and keeps an Overweight rating on the shares.
09/05/18
PIPR
09/05/18
NO CHANGE
Target $16
PIPR
Overweight
Piper sees less competition for Vericel after Histogenics data
Piper Jaffray analyst Edward Tenthoff raised his price target for Vericel (VCEL) to $16 from $14 after Histogenics (HSGX) reported its Phase III trial of NeoCart to repair knee cartilage defects narrowly missed its primary endpoint of dual threshold responder analysis compared to microfracture in 249 patients at one-year. While Histogenics still intends to meet with the FDA to discuss biologics license application filing, Tenthoff believes a "lack of durable data removes a potential competitor" for Vericel. He continues to project $80M in sales this year for Vericel and increased his 2019 sales estimate to $96.5M. The analyst remains Overweight rating on Vericel.
07/16/18
LTCO
07/16/18
UPGRADE
Target $13
LTCO
Buy
Vericel upgraded to Buy from Neutral at Ladenburg
Ladenburg Thalmann analyst Kevin DeGeeter upgraded Vericel to Buy with a $13 price target.
06/20/18
LEER
06/20/18
NO CHANGE
LEER
Outperform
Vericel selloff overdone, says Leerink
Leerink analyst Danielle Antalffy notes that Vericel's (VCEL) shares have been volatile for the past a few weeks and traded lower in reaction to Histogenics' (HSGX) analyst day. The analyst believes the selloff in Vericel's shares was overdone, and would use the weakness as an entry point, given her view that Histogenics' NeoCart is not a meaningful competitive threat to MACI. Vericel maintains a virtual monopoly in a highly underpenetrated articular cartilage repair market, as well as an actual monopoly in the severe burn market, she contends. Antalffy reiterates an Outperform rating on Vericel's shares.

TODAY'S FREE FLY STORIES

TSLA

Tesla

$354.46

6.09 (1.75%)

06:12
11/19/18
11/19
06:12
11/19/18
06:12
Conference/Events
Tesla management to meet with RBC Capital »

Group luncheon with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

  • 27

    Nov

  • 13

    Dec

HP

Helmerich & Payne

$62.59

2.54 (4.23%)

06:12
11/19/18
11/19
06:12
11/19/18
06:12
Upgrade
Helmerich & Payne rating change  »

Helmerich & Payne…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTI

W&T Offshore

$6.13

0.02 (0.33%)

06:11
11/19/18
11/19
06:11
11/19/18
06:11
Conference/Events
W&T Offshore management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

EV

Eaton Vance

$42.62

-0.435 (-1.01%)

06:11
11/19/18
11/19
06:11
11/19/18
06:11
Downgrade
Eaton Vance rating change  »

Eaton Vance downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPR

Tapestry

$40.63

-0.36 (-0.88%)

06:10
11/19/18
11/19
06:10
11/19/18
06:10
Conference/Events
Tapestry management to meet with MKM Partners »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

TPR

Tapestry

$40.63

-0.36 (-0.88%)

06:10
11/19/18
11/19
06:10
11/19/18
06:10
Conference/Events
Tapestry management to meet with MKM Partners »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

USB

U.S. Bancorp

$54.93

0.26 (0.48%)

06:10
11/19/18
11/19
06:10
11/19/18
06:10
Recommendations
U.S. Bancorp analyst commentary  »

U.S. Bancorp positioned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TELL

Tellurian

$8.03

0.11 (1.39%)

06:10
11/19/18
11/19
06:10
11/19/18
06:10
Conference/Events
Tellurian management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

CRM

Salesforce

$132.59

0.09 (0.07%)

06:09
11/19/18
11/19
06:09
11/19/18
06:09
Periodicals
Salesforce CEO defends contract with Customs and Border Patrol, Recode reports »

Salesforce CEO Marc…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 27

    Nov

  • 27

    Nov

  • 28

    Nov

  • 29

    Nov

  • 06

    Dec

  • 11

    Dec

  • 03

    Mar

OSK

Oshkosh

$66.91

-0.46 (-0.68%)

06:09
11/19/18
11/19
06:09
11/19/18
06:09
Conference/Events
Oshkosh management to meet with Buckingham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 04

    Dec

  • 05

    Dec

VICI

VICI Properties

$21.29

0.16 (0.76%)

06:09
11/19/18
11/19
06:09
11/19/18
06:09
Initiation
VICI Properties initiated  »

VICI Properties initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

CARG

CarGurus

$38.76

0.31 (0.81%)

06:08
11/19/18
11/19
06:08
11/19/18
06:08
Initiation
CarGurus initiated  »

CarGurus initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

KOP

Koppers Holdings

$20.18

-1.315 (-6.12%)

06:08
11/19/18
11/19
06:08
11/19/18
06:08
Conference/Events
Koppers Holdings management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

  • 26

    Nov

  • 27

    Nov

CMRE

Costamare

$5.35

0.01 (0.19%)

06:07
11/19/18
11/19
06:07
11/19/18
06:07
Hot Stocks
Costamare acquires 60% equity interest in five 14,000 TEU containerships »

Costamare announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INXN

Interxion

$64.10

0.62 (0.98%)

06:07
11/19/18
11/19
06:07
11/19/18
06:07
Conference/Events
Interxion management to meet with SunTrust »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

FRPT

Freshpet

$35.47

0.22 (0.62%)

06:06
11/19/18
11/19
06:06
11/19/18
06:06
Conference/Events
Freshpet management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

PDS

Precision Drilling

$2.48

0.01 (0.40%)

06:05
11/19/18
11/19
06:05
11/19/18
06:05
Hot Stocks
Precision Drilling announces expiration of waiting period for Trinidad deal »

Precision Drilling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

EVFM

Evofem

$3.45

0.01 (0.29%)

06:05
11/19/18
11/19
06:05
11/19/18
06:05
Conference/Events
Evofem management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 27

    Nov

YETI

Yeti

$16.99

0.1 (0.59%)

06:05
11/19/18
11/19
06:05
11/19/18
06:05
Initiation
Yeti initiated  »

Yeti initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

BPY

Brookfield Property

$18.48

-0.04 (-0.22%)

06:04
11/19/18
11/19
06:04
11/19/18
06:04
Conference/Events
Brookfield Property management to meet with Oppenheimer »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

PGR

Progressive

$66.28

-0.03 (-0.05%)

06:04
11/19/18
11/19
06:04
11/19/18
06:04
Upgrade
Progressive rating change  »

Progressive upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVTR

Nuvectra

$18.43

0.29 (1.60%)

06:04
11/19/18
11/19
06:04
11/19/18
06:04
Initiation
Nuvectra initiated  »

Nuvectra initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

ESRX

Express Scripts

$97.66

0.23 (0.24%)

06:04
11/19/18
11/19
06:04
11/19/18
06:04
Hot Stocks
Express Scripts announces strategic alliance with Petco for pet medicine »

Petco and Express Scripts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATVI

Activision Blizzard

$50.95

-2.6 (-4.86%)

06:04
11/19/18
11/19
06:04
11/19/18
06:04
Conference/Events
Activision Blizzard management to meet with Wedbush »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

TPC

Tutor Perini

$17.82

0.22 (1.25%)

06:04
11/19/18
11/19
06:04
11/19/18
06:04
Hot Stocks
Tutor Perini awarded $799.5M contract for Southwest Light Rail Transit project »

Tutor Perini announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.